This is a cracking announcement, not that it will gain much traction in current market.
Pre-clinical mouse model showing greater effectiveness from AD-214 as compared to the 2 drugs currently in the market for IPF.
Still on track for mid-year first patient dosing in the phase 1 trial.
It's a happy buy and wait for me
Ann: AD-214 effective in gold standard pre-clinical animal model, page-2
Add 1AD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $13.33M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.7¢ | 2.5¢ | $26.44K | 1.028M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 664357 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 54121 | 1 |
View Market Depth
| Last trade - 11.14am 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.7¢ |
Change
-0.001 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 2.5¢ | 2.7¢ | 2.5¢ | 103667 | ||
| Last updated 10.37am 29/05/2024 ? | |||||
| 1AD (ASX) Chart |